I had high hope for this share but from highs of around 15p when Salistick was announced it has been a steady drip down, DX Loop has been a damp squid where we go from here is anybody’s guess.
Latest web update partner with us contact us smells of desperation, What AVACTA need is a good PR company somebody to keep the company in the spotlight .
Hope CC is going to pull a rabbit out of the hat and announce new news that will stabilise the SP, To see the price back to the placing is disappointing but that’s AVACTA for you never fails to disappoint .
Would appear investors are losing faith in Avacta good interview with CC but the SP still dives, The information with the testing is out there but BP are taking no notice .Its going to take a stellar RNS to stop the rot or the worst could happen and Avacta become a footnote in history.
Disappointing to see the downward pressure on a daily basis, hopefully not a precursor to a raise only way a raise is viable is if stellar clinical results are announced. Otherwise its the downward spiral could lead to a complete loss of confidence in the company.
What’s the consensus for the next payment cash or shares if cash then another raise is on the cards,Unless a license deal or sale can be arranged about time the expensive none scientific staff proved there worth.Only problem is who is going to partner with Avacta after the last RNS.
This feels like a pivotal moment in Avactas journey you either believe in the Precision platform or doubt it , The RNS was unfortunately worded badly minor response was the killer quote. So we are now in a downward spiral all self inflicted.
I assume minor response means no significant improvement after dosing that can’t be good ,Must be why the SP has tanked and explains BP disinterest in Avacta.
Once again BP are not interested in Avacta the RNS has had the usual affect on the SP down again, Nobody is going to get rich any time soon so its the same old same old a raise and price tank to look forward to and the frenzy how there going to pay the next loan instalment.